Evidence map›Paper›PMID 29456185›Full record

ArticleStem cell reports2018

Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models.

Anders Lundin, Louise Delsing, Maryam Clausen, Piero Ricchiuto, José Sanchez, Alan Sabirsh, Mei Ding, Jane Synnergren, Henrik Zetterberg, Gabriella Brolén and 3 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 147 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Astrocytes as Therapeutic Targets in Neurodegenerative Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Anders LundinDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden; Department of Neuroscience, Karolinska Institutet, Stockholm 17177, Sweden.
Louise DelsingDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden; Systems Biology Research Center, School of Bioscience, University of Skövde, Skövde 54128, Sweden; Institute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal 41345, Sweden.
Maryam ClausenDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden.
Piero RicchiutoDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden.
José SanchezDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden.
Alan SabirshPharmaceutical Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden.
Mei DingDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden.
Jane SynnergrenSystems Biology Research Center, School of Bioscience, University of Skövde, Skövde 54128, Sweden.
Henrik ZetterbergInstitute of Neuroscience and Physiology, Department of Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal 41345, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal 41345, Sweden; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; UK Dementia Research Institute at UCL, London WC2B 4AN, UK.
Gabriella BrolénDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden.
Ryan HicksDiscovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal 43150, Sweden.
Anna HerlandDepartment of Micro and Nanosystems KTH Royal Institute of Technology, Stockholm 10044, Sweden; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: aherland@kth.se.
Anna FalkDepartment of Neuroscience, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: anna.falk@ki.se.
AstraZeneca (Sweden) · SEKarolinska Institutet · SEKTH Royal Institute of Technology · SESahlgrenska University Hospital · SEUniversity of Gothenburg · SEUniversity of Skövde · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vivo studies of human brain cellular function face challenging ethical and practical difficulties. Animal models are typically used but display distinct cellular differences. One specific example is astrocytes, recently recognized for contribution to neurological diseases and a link to the genetic risk factor apolipoprotein E (APOE). Current astrocytic in vitro models are questioned for lack of biological characterization. Here, we report human induced pluripotent stem cell (hiPSC)-derived astroglia (NES-Astro) developed under defined conditions through long-term neuroepithelial-like stem (ltNES) cells. We characterized NES-Astro and astrocytic models from primary sources, astrocytoma (CCF-STTG1), and hiPSCs through transcriptomics, proteomics, glutamate uptake, inflammatory competence, calcium signaling response, and APOE secretion. Finally, we assess modulation of astrocyte biology using APOE-annotated compounds, confirming hits of the cholesterol biosynthesis pathway in adult and hiPSC-derived astrocytes. Our data show large diversity among astrocytic models and emphasize a cellular context when studying astrocyte biology.

Indexed as

Apolipoproteins EAstrocytesBrainCell DifferentiationCells, CulturedHumansInduced Pluripotent Stem CellsNeural Stem CellsNeuronsApolipoproteins Eapolipoproteins Eastrocytescalcium signalingcell differentiationdrug discoveryglutamate plasma membrane transport proteinshigh-throughput screening assaysinduced pluripotent stem cellsneurodegenerative diseasesneuroinflammation

Identifiers

PMID29456185
PMCPMC5918339
OpenAlexW2786430800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.